Related Experiment Video

Updated: Jun 17, 2026

Workflow and Framework for Collecting and Implementing Point-of-Care Ultrasound Data in the Management of Heart Failure Patients
03:47

Workflow and Framework for Collecting and Implementing Point-of-Care Ultrasound Data in the Management of Heart Failure Patients

Published on: July 12, 2024

Heart failure registry: a valuable tool for improving the management of patients with heart failure

Asa Jonsson1, Magnus Edner, Urban Alehagen

  • 1Department of Cardiology, Ryhov County Hospital, Jönköping, Sweden. asa.jonsson@lj.se

European Journal of Heart Failure
|December 22, 2009
PubMed

Insights

The Swedish Heart Failure Registry (S-HFR) helps improve heart failure (HF) patient care by providing online data. This tool supports centers in optimizing diagnosis and treatment for better patient outcomes.

Area of Science:

  • Cardiology
  • Health Informatics
  • Public Health

Background:

  • Established guidelines for heart failure (HF) diagnosis and treatment exist, yet many patients are not adequately diagnosed or treated.
  • The Swedish Heart Failure Registry (S-HFR) was developed to address these gaps and optimize HF patient management.

Purpose of the Study:

  • To evaluate the utility of the Swedish Heart Failure Registry (S-HFR) as a tool for improving the diagnosis and treatment of heart failure (HF) patients.
  • To assess the current management practices and patient characteristics within the S-HFR.

Main Methods:

  • The S-HFR is an internet-based registry collecting data from participating centers on HF patients.
  • Data includes patient demographics, diagnostic test results (ECG, echocardiography), and medication use.
  • By December 2007, 16,117 patients from 78 units were included, with 10,229 followed for at least one year.

Main Results:

  • Electrocardiograms were available for 97% of patients; 51% were in sinus rhythm, and 38% in atrial fibrillation.
  • Echocardiography was performed in 83% of patients.
  • Pharmacological treatment included angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers (77%), beta-blockers (80%), aldosterone antagonists (34%), and diuretics (83%).

Conclusions:

  • The S-HFR is a valuable tool for enhancing the management of heart failure (HF) patients.
  • Online reports from the registry empower participating centers to identify areas for improvement in diagnosis and medical treatment.
  • The registry facilitates focused efforts to optimize patient care pathways and outcomes.
Abstract

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.